Regeneron Pharmaceuticals REGN Valuation Assessment Following European Dupixent Indication Expansion News Analysis Fed officials are growing anxious about the Iran war DELL Dell Tech Q1 2026 results top EPS estimates shares rise 32 percent on 188 percent year over year revenue growth Merck Co Inc MRK Poised to Drive RD and Operational Efficiency via New Google Cloud Agentic AI Partnership MAZE Maze Therapeutics posts narrower Q4 2025 loss than consensus estimates shares dip 077 percent today vTv Therapeutics Q1 2026 Earnings EPS Surges to 165 Far Above Estimates Despite No Reported Revenue Tecogen Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares RCKT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Clinical Progress KORE Q1 2026 Earnings Massive EPS Miss Revenue Data Unavailable Kayne Anderson Energy Infrastructure Fund Inc KYN Q4 2015 Earnings EPS Miss Amidst Challenging Energy Environment ECAT Posts Modest Gains as Shares Hold Above Key Support Zone USA Rare Earth Inc USAR Declines 37 as Support Levels Harden Limbach Holdings LMB Edges Higher Approaching Key Resistance Level AMETEK Inc AME Edges Higher Modest Gain Amid Sector Stability MDU Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Movement